KCM
SYRS

Kennedy Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Kennedy Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-427,536
Closed -$2.21M – 742
2024
Q2 		$2.21M Buy
427,536
+22,622
+6% +$117K 0.05% 498
2024
Q1 		$2.17M Buy
+404,914
New +$2.17M 0.04% 505